Nymox Pharmaceutical Corp (NYMXF)

Currency in USD
0.0700
-0.0040(-5.41%)
Closed·
NYMXF Scorecard
Full Analysis
Stock has taken a big hit over the last week
NYMXF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.07000.0700
52 wk Range
0.00030.3099
Key Statistics
Prev. Close
0.074
Open
0.07
Day's Range
0.07-0.07
52 wk Range
0.0003-0.3099
Volume
1.57K
Average Volume (3m)
20.27K
1-Year Change
48%
Book Value / Share
-0.07
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NYMXF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Nymox Pharmaceutical Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Nymox Pharmaceutical Corp Company Profile

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert for determining smoking status; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer’s disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, Bahamas.

Compare NYMXF to Peers and Sector

Metrics to compare
NYMXF
Peers
Sector
Relationship
P/E Ratio
−1.6x−0.4x−0.5x
PEG Ratio
−0.030.000.00
Price/Book
−1.0x0.7x2.6x
Price / LTM Sales
-9.5x3.3x
Upside (Analyst Target)
-329.2%43.3%
Fair Value Upside
Unlock23.7%6.9%Unlock

Earnings

Latest Release
Jun 03, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NYMXF Income Statement

FAQ

What Stock Exchange Does Nymox Pharmaceutical Trade On?

Nymox Pharmaceutical is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Nymox Pharmaceutical?

The stock symbol for Nymox Pharmaceutical is "NYMXF."

What Is the Nymox Pharmaceutical Market Cap?

As of today, Nymox Pharmaceutical market cap is 6.62M.

What Is Nymox Pharmaceutical's Earnings Per Share (TTM)?

The Nymox Pharmaceutical EPS (TTM) is -0.05.

From a Technical Analysis Perspective, Is NYMXF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Nymox Pharmaceutical Stock Split?

Nymox Pharmaceutical has split 0 times.

How Many Employees Does Nymox Pharmaceutical Have?

Nymox Pharmaceutical has 16 employees.

What is the current trading status of Nymox Pharmaceutical (NYMXF)?

As of 11 Aug 2025, Nymox Pharmaceutical (NYMXF) is trading at a price of 0.07, with a previous close of 0.07. The stock has fluctuated within a day range of 0.07 to 0.07, while its 52-week range spans from 0.00 to 0.31.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.